Estimated effectiveness of vaccines and extended half-life monoclonal antibodies against respiratory syncytial virus (RSV) hospitalizations in young children

Zhe Zheng, Daniel M. Weinberger, Virginia E. Pitzer
doi: https://doi.org/10.1101/2022.04.19.22272855

Article usage

Article usage: April 2022 to January 2025

AbstractFullPdf
Apr 20223771059
May 2022109328
Jun 202277013
Jul 202278013
Aug 202258417
Sep 202259011
Oct 202211009
Nov 202257124
Dec 202229415
Jan 20231407
Feb 202319211
Mar 20231507
Apr 20231813
May 20231313
Jun 2023945
Jul 2023915
Aug 202312104
Sep 2023941
Oct 2023925
Nov 20231961
Dec 20231624
Jan 20242327
Feb 20241405
Mar 2024707
Apr 20248311
May 20241723
Jun 2024929
Jul 2024606
Aug 2024602
Sep 20241633
Oct 2024552
Nov 20241016
Dec 2024318
Jan 2025100
Back to top
Posted April 20, 2022.
Download PDF

Supplementary Material

Data/Code
Email
Estimated effectiveness of vaccines and extended half-life monoclonal antibodies against respiratory syncytial virus (RSV) hospitalizations in young children
Zhe Zheng, Daniel M. Weinberger, Virginia E. Pitzer
medRxiv 2022.04.19.22272855; doi: https://doi.org/10.1101/2022.04.19.22272855
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area